semaglutide tirzepatide weight loss mechanism Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review Frontiers | Tirzepatide against obesity

The combination of GLP-1 and GIP receptor activation in the central nervous system may achieve more balanced and sustained effects on energy homeostasis compared to targeting either pathway alone

Transparency has always been a clinic priority, ensuring patients have access to comprehensive information on all available treatments to make well-informed choices

GIP is another incretin hormone released by the gut

It helps you feel full sooner, stay satisfied longer, and manage cravings, while also supporting steady blood sugar and improved metabolic health

Retatrutide-related nausea, vomiting, diarrhea, or reduced food and fluid intake can also increase the risk of dehydration

Some patients respond very well to GLP-1-based medications and achieve steady weight loss with this approach